Received Dec 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | X5FN4 | IM / LA |
Patient experienced extreme redness, pain, and inflammation at site of injection. Symptoms were still present 2 days after injection.
Same reaction to dose #1 of shingrix